AccutarBio Company

AccutarBio employs artificial intelligence to revolutionize drug discovery.
Technology: Artificial Intelligence, Biopharma, Biotechnology, Machine Learning
Industry: AI, Early Drug Development
Headquarters: Shanghai, Shanghai, China
Founded Date: 2015-01-01
Employees Number: 11-50
Funding Status: Early Stage Venture
Investors Number: 3
Total Funding: 76613745
Estimated Revenue: Less than $1M
Last Funding Date: 2021-01-05
Last Funding Type: Venture - Series Unknown

Visit Website
Register and Claim Ownership